Navigation Links
Pneumonia Vaccine Is Keeping Kids Healthier
Date:12/7/2007

New shot has cut hospitalizations by more than half, CDC study finds

FRIDAY, Dec. 7 (HealthDay News) -- Among children younger than 2, receiving the pneumococcal vaccine appears to be associated with fewer hospitalizations for pneumonia and reduced health-care expenses, according to a new report from the U.S. Centers for Disease Control and Prevention.

Beginning in 2000, the 7-valent pneumococcal conjugate vaccine (PDV7) became part of the routine immunization schedule for American children, according to background information in a news release about the study.

The vaccine -- which protects against pneumococcal pneumonia, caused by the Streptococcus pneumoniae bacteria -- is recommended for all children aged 2 months to 23 months and children aged 24 months to 59 months who are at increased risk for pneumococcal disease.

Between 2002 and 2005, the number of American children aged 19 months to 35 months receiving three or more doses of the PDV7 vaccine increased from 41 percent to 83 percent.

For this study, the CDC researchers analyzed 1997 to 2004 health records from a database of about 40 large U.S. employers. The findings are published in the December issue of the Archives of Pediatrics & Adolescent Medicine.

"Comparing the rates in 2004 with those in the baseline period of 1997 to 1999 among children younger than two years, hospitalizations due to all-cause pneumonia declined from 11.5 to 5.5 per 1,000 children (52.4 percent decline) and ambulatory (outpatient) visits due to all-cause pneumonia declined from 99.3 to 58.5 per 1,000 children (41.1 percent decline)," the study authors wrote.

"Rates of hospitalization due to pneumococcal pneumonia declined from 0.6 to 0.3 per 1,000 children (57.6 percent decline) and rates of ambulatory visits declined from 1.7 to 0.9 per 1,000 children (46.9 percent decline)," the authors added.

The findings add to growing evidence of the benefits of PCV7 vaccination and suggest the vaccine plays an important role in reducing pneumonia rates and health-care costs, the authors concluded.

More information

Visit the U.S. Centers for Disease Control and Prevention for more about child immunizations.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Dec. 3, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Zinc Helps Elderly Ward Off Pneumonia
2. Heart attacks/pneumonia falls short of national goals
3. Emergency Care for Heart Attacks, Pneumonia Fails to Meet Goals
4. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
5. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
6. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
7. Vaccine Stops Alzheimers Brain Tangles
8. Human Papilloma Virus vaccines may decrease chances of oral cancer
9. U.S. Teens Fall Short on Vaccine Coverage
10. Nasal Anthrax Vaccine Proves Effective in Animal Study
11. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... , ... June 28, 2017 , ... Anyone with a remote control has seen the ... do it, you the flipper will get rich in no time. But what about ... things can get for the buyer of a flipped house. An email recently sent ...
(Date:6/28/2017)... ... June 28, 2017 , ... David B. Sosin, a founding partner at ... over the post of 2nd Vice President for the Illinois State Bar Association , ... the ISBA’s 3rd Vice President in 2016 following a state-wide election and served in that ...
(Date:6/28/2017)... ... June 28, 2017 , ... American Farmer proudly announces the participation of Pure ... television series, scheduled to broadcast fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET ... of garden pea seed. As demand grew, the small company located in Moscow, Idaho ...
(Date:6/28/2017)... ... June 28, 2017 , ... Canadian Zeolite Corp. (the “Company”) ... year study conducted by the University of Saskatchewan in partnership with PotashCorp, Agrium ... brine-impacted groundwater. As a part of the study, batch adsorption experiments were conducted ...
(Date:6/28/2017)... ... June 28, 2017 , ... Doner ... surrounding regions access to insurance assistance and financial planning services, is announcing the ... assist families in the region facing financial crisis. , Matthew 25: Ministries (M25M) ...
Breaking Medicine News(10 mins):
(Date:6/11/2017)...  Eli Lilly and Company (NYSE: LLY ) ... of galcanezumab, an investigational treatment for the prevention of ... key secondary endpoints for galcanezumab compared to placebo at ... EVOLVE-2 and REGAIN) will be presented today at the ... Boston . "The detailed ...
(Date:6/8/2017)... Fla. , June 8, 2017  Less than ... that hit more than 200,000 companies, including hospital networks, ... being heralded as one of the largest online extortion ... in the healthcare market, it is imperative that providers ... protect their data from this — and many other ...
(Date:6/7/2017)... Inc., (Nasdaq: NVAX ) today announced that data ... RSV F protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) ... the journal Vaccine (the data contained ... The Company previously announced top line results from ... F Vaccine with the goal of protecting infants from RSV ...
Breaking Medicine Technology: